| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Dec-30-21 | Sep-30-21 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K | 10-Q |
| Revenues: |
| Industrial Injury Prevention Services Revenues | 19.2 | 18.4 | 20.2 | 19.4 | 19.1 | 13.4 | | 10.5 |
| Physical Therapy Operations | 132.2 | 122.8 | 119.4 | 121.2 | 112.6 | 116.5 | | 115.4 |
| Total revenues | 151.5 | 141.2 | 139.6 | 140.7 | 131.7 | 129.8 | | 125.9 |
| Revenue growth [+] | 7.7% | 8.7% | 10.9% | 10.8% | 17.2% | 10.5% | | 15.6% |
| Industrial Injury Prevention Services Revenues | -1.0% | 37.6% | 92.1% | 93.7% | 90.5% | 38.5% | | 4.8% |
| Physical Therapy Operations | 9.1% | 5.4% | 3.5% | 3.7% | 10.0% | 2.6% | | 19.1% |
| Cost of goods sold | 86.9 | 82.3 | 81.8 | 79.9 | 75.1 | 75.3 | | 70.5 |
| Gross profit | 64.6 | 58.9 | 57.8 | 60.7 | 56.6 | 54.5 | | 55.4 |
| Gross margin | 42.7% | 41.7% | 41.4% | 43.2% | 42.9% | 42.0% | | 44.0% |
| Selling, general and administrative [+] | 12.1 | 11.9 | 11.9 | 10.7 | 11.6 | 10.7 | | 12.9 |
| General and administrative | | 11.9 | | | | 10.7 | | |
| Equity in earnings | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.1 | | |
| Other operating expenses | 32.4 | 31.0 | 31.0 | 29.9 | 30.0 | 27.4 | | 25.6 |
| EBITDA [+] | | 19.9 | 18.9 | 23.9 | 19.2 | 19.6 | | 20.0 |
| EBITDA growth | -14.7% | 1.2% | -5.6% | -4.5% | 8.4% | 17.3% | | -12.2% |
| EBITDA margin | 13.5% | 14.1% | 13.5% | 17.0% | 14.6% | 15.1% | | 15.9% |
| Depreciation | -1.8 | 2.1 | 2.1 | 2.4 | 1.6 | 2.1 | | 2.0 |
| EBITA | 22.2 | 17.8 | 16.7 | 21.5 | 17.6 | 17.5 | | 17.9 |
| EBITA margin | 14.6% | 12.6% | 12.0% | 15.3% | 13.3% | 13.5% | | 14.2% |
| Amortization of intangibles | 1.8 | 1.7 | 1.5 | 1.1 | 2.2 | 1.0 | | 1.0 |
| EBIT [+] | 20.4 | 16.1 | 15.2 | 20.4 | 15.4 | 16.6 | | 16.9 |
| EBIT growth | -0.2% | -2.9% | -10.2% | -8.1% | 2.3% | 16.1% | | -15.4% |
| EBIT margin | 13.5% | 11.4% | 10.9% | 14.5% | 11.7% | 12.8% | | 13.4% |
| Non-recurring items | | 9.1 | | | | | | |
| Interest income | 0.7 | 0.1 | 0.1 | 0.7 | 0.0 | 0.0 | | 0.1 |
| Interest income | 0.7 | 0.1 | 0.1 | 0.7 | 0.0 | 0.0 | | 0.1 |
| Other income (expense), net [+] | -2.0 | -2.5 | 0.8 | -1.6 | 0.1 | 1.8 | | 0.9 |
| Litigation settlement | | | | | | -2.6 | | |
| Pre-tax income | 19.1 | 4.6 | 16.0 | 19.5 | 15.5 | 18.4 | | 17.9 |
| Income taxes | 4.2 | 1.2 | 3.2 | 4.2 | 3.5 | 3.9 | | 3.8 |
| Tax rate | 22.2% | 26.6% | 20.0% | 21.7% | 22.6% | 21.5% | | 21.3% |
| Minority interest | 3.9 | 0.7 | 3.3 | 4.1 | 3.2 | 4.2 | | 4.1 |
| Net income | 10.9 | 2.6 | 9.6 | 11.2 | 8.8 | 10.2 | | 10.0 |
| Net margin | 7.2% | 1.8% | 6.8% | 8.0% | 6.7% | 7.9% | | 8.0% |
| |
| Basic EPS [+] | $0.80 | $0.20 | $0.74 | $0.86 | $0.68 | $0.79 | | $0.78 |
| Growth | -7.6% | -74.6% | -5.2% | -10.6% | 7.1% | -22.0% | | -8.7% |
| Diluted EPS [+] | $0.80 | $0.20 | $0.74 | $0.86 | $0.68 | $0.79 | | $0.78 |
| Growth | -7.6% | -74.6% | -5.2% | -10.6% | 7.1% | -22.0% | | -8.7% |
| |
| Dividends per share [+] | $0.43 | $0.41 | $0.41 | $0.41 | $0.41 | $0.38 | | $0.38 |
| Growth | 4.9% | 7.9% | 7.9% | 17.1% | 17.1% | | | |
| |
| Shares outstanding (basic) [+] | 13.7 | 13.0 | 13.0 | 13.0 | 12.9 | 12.9 | | 12.9 |
| Growth | 5.6% | 0.7% | 0.7% | 0.7% | 0.5% | 0.5% | | 0.5% |
| Shares outstanding (diluted) [+] | 13.7 | 13.0 | 13.0 | 13.0 | 12.9 | 12.9 | | 12.9 |
| Growth | 5.6% | 0.7% | 0.7% | 0.7% | 0.5% | 0.5% | | 0.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |